...
首页> 外文期刊>Journal of Clinical Microbiology >Characterization of Ertapenem-Resistant Enterobacter cloacae in a Taiwanese University Hospital
【24h】

Characterization of Ertapenem-Resistant Enterobacter cloacae in a Taiwanese University Hospital

机译:台湾大学附属医院的耐厄他培南的阴沟肠杆菌的鉴定

获取原文
           

摘要

The emergence of carbapenem resistance in Enterobacteriaceae has become a great concern. The aim of this study was to characterize ertapenem-resistant Enterobacter cloacae isolates from a Taiwanese university hospital. A total of 355 nonduplicated E. cloacae isolates collected in 2007 were analyzed by antimicrobial susceptibility testing with and without an inhibitor of efflux pumps and AmpC β-lactamase. The phenotype of extended-spectrum β-lactamase (ESBL), profile of outer membrane proteins (OMPs), and clonal relatedness were investigated by the double-disk synergy test, urea/SDS-PAGE, and pulsed-field gel electrophoresis (PFGE), respectively. β-Lactamase genes were examined by PCR and sequencing, and the expression of efflux pump gene acrB was evaluated by reverse transcription-PCR. The contribution of porin deficiency to resistance was investigated by restoring functional porin genes on plasmids. We demonstrated that ertapenem resistance was prevalent (53/355; 14.9%) in E. cloacae. Among the strains, IMP-8, SHV-12, and TEM-1 β-lactamases were identified in 3 (5.7%), 40 (75.5%), and 46 (86.8%) isolates, respectively. PFGE showed clonal diversity among these isolates. Phenotypes of ESBL, AmpC β-lactamase overproduction, an active efflux pump, and change in the expression of OMPs were found in 18 (34%), 11 (20.8%), 51 (96.2%), and 23 (43.4%) of ertapenem-resistant strains, respectively. Ertapenem MICs were restored in strains with OmpC and OmpF expression plasmids. This study suggests that ESBL, AmpC β-lactamase overproduction, and decreased OMP expression combined with an active efflux pump contribute to the ertapenem resistance of E. cloacae. The presence of IMP-8 may also play a partial role in ertapenem resistance in Taiwan.
机译:肠杆菌科中对碳青霉烯类药物的耐药性已引起人们的高度关注。这项研究的目的是鉴定台湾大学医院对耐厄他培南的阴沟肠杆菌的分离株。在有和没有外排泵抑制剂和AmpCβ-内酰胺酶的情况下,通过抗菌药敏试验分析了2007年收集的总共355株阴沟肠杆菌。通过双盘协同试验,尿素/ SDS-PAGE和脉冲场凝胶电泳(PFGE)研究了广谱β-内酰胺酶(ESBL)的表型,外膜蛋白(OMPs)的概况以及克隆相关性。 , 分别。通过PCR和测序检查β-内酰胺酶基因,并通过逆转录PCR评估外排​​泵基因 acrB 的表达。通过在质粒上恢复功能性孔蛋白基因来研究孔蛋白缺乏对抗性的贡献。我们证明了对厄他培南的耐药性在阴沟肠杆菌中普遍存在(53/355; 14.9%)。在菌株中,分别在3株(5.7%),40株(75.5%)和46株(86.8%)菌株中鉴定出IMP-8,SHV-12和TEM-1β-内酰胺酶。 PFGE显示出这些分离株之间的克隆多样性。在18例(34%),11例(20.8%),51例(96.2%)和23例(43.4%)中发现了ESBL的表型,AmpCβ-内酰胺酶超量生产,主动外排泵和OMPs表达的变化。分别具有耐厄他培南的菌株。用OmpC和OmpF表达质粒在菌株中恢复了厄他培南MIC。这项研究表明,ESBL,AmpCβ-内酰胺酶的过量生产以及OMP表达的降低与主动外排泵相结合,有助于阴沟肠杆菌对厄他培南的抵抗。在台湾,IMP-8的存在也可能在抗ertapenem中起部分作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号